3F BIO

3fbioscientist2.jpg
3fBio 480x370 May2018.jpg

"For 3F BIO, as a new micro-SME spin-out company, accessing world class expertise, guidance, facilities and support is an essential element in building our potential for success. Based within University of Strathclyde, becoming part of the IBioIC community and accessing IBioiC’s Rapid Bioprocess Prototype Centre (RBPC) has been an essential part of delivering our ambitious development program."

"3F BIO have been operating within RBPC facilities for several months delivering our Proof of Concept program whilst commissioning the equipment and operating systems.

Operating on the scale range of 1 to 15 litres allows us to both deliver Proof of Concept demonstration and develop a 2 year forward plan to use the facility as a commercial development base.

- David Ritchie, CTO, 3F BIO

 

"3F BIO has a vision to address global needs for sustainable protein. Our objective is to commercialise novel patented technology for the integrated production of mycoprotein within existing large scale biorefineries. We believe that this zero-waste technology which was developed within the University of Strathclyde can halve the production cost of mycoprotein, the protein component in QuornTM, to unlock its potential to be a genuine high quality protein solution for growing global populations.

Building on successful partnerships with the University of Strathclyde and IBioIC, 3F BIO are working to establish collaborative and partnership models with leading commercial operators to efficiently develop and deliver the technology at industrial scale. 

2016 has been an exciting year the company. We have established ambitious technical and commercial programs and have been honoured to receive awards from the University of Strathclyde, EFIB Pitchfest in Glasgow and HiE’s Innovation Challenge in Frankfurt.  In addition to this, we are putting in place the funding solutions for the next phase of the business.
We are intensely grateful for the support, infrastructure and network provided by IBioIC to date and collectively this will continue to be integral to how we progress and develop the next phase of our plans.
"

- Jim Laird, CEO, 3F BIO

https://www.3fbio.com/